Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Shareholders held by Ginkgo Bioworks Holdings, Inc. on June 11, 2026. The filing details the voting results for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Shareholder participation was significant, with approximately 77.15% of Class A and Class B shares (voting as a single class) and 93.77% of Class B shares (voting separately) present or represented by proxy.
1. Election of Directors
All six nominees were elected to the Board of Directors.
- Class B Designated Nominees: Jason Kelly and Reshma Shetty received overwhelming support with 84,007,040 votes for and 48,210 votes against each.
- Single Class Nominees: Ross Fubini, Christian Henry, Sri Kosuri, and Harry E. Sloan were elected. Christian Henry received the highest number of "Against" votes (13,927,076) among the single-class nominees, while Ross Fubini received the most "For" votes (100,125,571).
2. Ratification of Independent Auditor
Shareholders approved the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes For: 119,527,721
- Votes Against: 267,727
- Abstentions: 3,796,650
3. Advisory Vote on Executive Compensation
The advisory vote to approve the compensation of named executive officers was approved.
- Votes For: 95,058,585
- Votes Against: 12,502,153
- Abstentions: 4,238,463
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific reasons for the higher "Against" vote count for director nominee Christian Henry compared to other nominees.
- Confirm the total number of shares outstanding to contextualize the 11.79 million broker non-votes recorded for director and compensation proposals.
- Review the full proxy statement for details on the executive compensation package approved in Proposal 3.
- Check subsequent filings for the official appointment of the newly elected directors and any changes to board committees.